Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2012
06/13/2012CN101343315B Shorten human papilloma virus 6 type L1 protein
06/13/2012CN101331150B Human monoclonal antibody human CD134 (OX40) and methods of making and using same
06/13/2012CN101166978B Metering technique for lateral flow assay devices
06/13/2012CN101141978B Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
06/13/2012CN101065144B Methods and compositions for treatment of hematologic cancers
06/12/2012USRE43467 Treatment of autoimmune disease
06/12/2012US8198430 Immunogenic sequences
06/12/2012US8198416 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
06/12/2012US8198412 Antibodies that recognize cutting edge within the TGF-β activation controlling region
06/12/2012US8198410 Nerve growth factor specific immunoglobulin for prevention and treatment of chronic pain, nervous system, inflammatory, skin and bone disorders; osteoarthritis
06/12/2012US8198400 Liposomal vaccines containing immunogenic lipopeptides from tuberculosis, malaria, and hepatitis B peptides
06/12/2012US8198292 Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof
06/12/2012US8198265 Regulation of T cell-mediated immunity by tryptophan
06/12/2012US8198234 Methods of suppressing microglial activation
06/12/2012US8198088 Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
06/12/2012US8198067 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins
06/12/2012US8197858 Use of calcitonin, SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonates such as risedronate
06/12/2012US8197827 Protein from Photobacterium damselae and use thereof
06/12/2012US8197826 Probiotic for enhancing immune response
06/12/2012US8197825 Recombinant MVA virus and the use thereof
06/12/2012US8197824 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
06/12/2012US8197823 Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
06/12/2012US8197822 Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)
06/12/2012US8197821 Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions
06/12/2012US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/12/2012US8197819 Exposure of epitopes on envelop protein; complex of polypeptide and antigen; induce immunology response
06/12/2012US8197818 EML4-ALK fusion gene
06/12/2012US8197817 Using serine/threonine enzyme inhibitors as therapeutic in treatment of cell proliferative and infection disorders
06/12/2012US8197816 Human monoclonal antibody specific for lipopolysaccharides (LPS) of the Pseudomonas aeruginosa IATS O11 serotype
06/12/2012US8197815 Anti-EphrinB2 antibodies and methods using same
06/12/2012US8197814 Method for treating the Th2-mediated disease
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012US8197812 IL-1-like cytokine antibodies
06/12/2012US8197811 Methods of use of sialoadhesin factor-2 antibodies
06/12/2012US8197810 Binding domain-immunoglobulin fusion proteins
06/12/2012US8197809 CD9-specific human antibodies
06/12/2012US8197430 Method and system to remove cytokine inhibitor in patients
06/12/2012CA2534060C Hepatitis virus core proteins as vaccine platforms and methods of use thereof
06/12/2012CA2495294C Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines
06/12/2012CA2463090C Recombinant rabies vaccine and methods of preparation and use
06/12/2012CA2404325C Immunotherapeutic methods and compositions
06/12/2012CA2363269C Dna vaccination for treatment of autoimmune disease
06/12/2012CA2288992C Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
06/12/2012CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/12/2012CA2180473C Cloning and characterization of h.pylori flba gene. production of aflagellate strains
06/10/2012CA2761402A1 Sheet-form preparation and method for producing the same
06/07/2012WO2012075490A2 Anti-podoplanin antibodies and methods of use
06/07/2012WO2012075428A1 Composition for immunization against streptococcus pneumoniae
06/07/2012WO2012075422A2 Compositions and methods for treating amyloid plaque associated symptoms
06/07/2012WO2012075379A2 Liquid viral formulations
06/07/2012WO2012075376A2 Lyophilized viral formulations
06/07/2012WO2012075361A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
06/07/2012WO2012075342A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012WO2012075340A2 Anti-ngf compositions and use thereof
06/07/2012WO2012075327A1 Methods for treating a tumor using an antibody that specifically binds grp94
06/07/2012WO2012075324A1 Methods for treating a tumor using an antibody that specifically binds hmw-maa
06/07/2012WO2012075111A1 Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
06/07/2012WO2012075037A1 Low affinity blood brain barrier receptor antibodies and uses therefor
06/07/2012WO2012074881A2 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
06/07/2012WO2012074773A1 Personalized drug treatment methods
06/07/2012WO2012074757A1 Alaninyl maytansinol antibody conjugates
06/07/2012WO2012074725A2 Immunomodulatory methods and systems for treatment and/or prevention of hypertension
06/07/2012WO2012074559A2 Treatment of non-proliferative cystic disease
06/07/2012WO2012074097A1 Anti-cd33 antibody
06/07/2012WO2012074043A1 Therapeutic agent for traumatic neurological disorders
06/07/2012WO2012073992A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
06/07/2012WO2012073985A1 Cytotoxicity-inducing therapeutic agent
06/07/2012WO2012073459A1 Tomm34 peptides and vaccines including the same
06/07/2012WO2012073047A2 Compositions and methods
06/07/2012WO2012072788A1 Vaccine against influenza h5n1 viruses, medicament and treatment of h5n1 viral infections
06/07/2012WO2012072769A1 Pneumococcal rrgb epitopes and clade combinations
06/07/2012WO2012072678A1 Hypoallergenic polypeptides for the treatment of house dust mite allergy
06/07/2012WO2012072088A1 Peptide scaffold design
06/07/2012WO2012071649A1 Covalently dimerized bivalent binding agents
06/07/2012WO2012071648A1 Egfr antagonist for the treatment of heart disease
06/07/2012WO2012051211A3 Antigen delivery platforms
06/07/2012WO2012050893A3 Immunogenic polypeptides having an immunogenic scaffold protein and a loop peptide, presenting a 3074- or 2219/2557- monoclonal antibody-targeted epitope, which is present in the hiv gp120 protein
06/07/2012WO2012047629A3 Selective removal of age-modified cells for treatment of ather0sclerosis
06/07/2012WO2012041867A3 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
06/07/2012WO2012040518A3 Carrier immunoglobulins and uses thereof
06/07/2012WO2012040456A3 Human b1 cells and uses thereof
06/07/2012WO2012038540A3 Peptide allergens
06/07/2012WO2012034197A8 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
06/07/2012WO2012033814A3 Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
06/07/2012WO2012031752A8 Tuberculosis mutants
06/07/2012WO2012024632A3 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
06/07/2012WO2012020123A9 Neuropilin as a biomarker for bevacizumab combination therapies
06/07/2012WO2012009774A3 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods
06/07/2012WO2011159814A3 Novel live recombinant booster vaccine against tuberculosis
06/07/2012WO2011151723A3 Concentration of influenza vaccine antigens without lyophilization
06/07/2012US20120144509 Novel strains of helicobacter pylori and uses thereof
06/07/2012US20120142611 Repeat protein from collection of repeat proteins comprising repeat modules
06/07/2012US20120142607 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
06/07/2012US20120142097 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120142096 Fusion proteins of hiv regulatory/accessory proteins
06/07/2012US20120141585 Immunomodulatory compositions comprising a polymer matrix and an oil phase
06/07/2012US20120141579 Cytotoxic T Lymphocyte Inducing Immunogens for Prevention Treatment and Diagnosis of Cancer
06/07/2012US20120141577 Linear expression cassette vaccines
06/07/2012US20120141564 Compositions and methods of treating inflammation
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 1823